Physician

Amishi Desai

According to 2025 Medicare claims, Amishi Desai (NPI: 1902141914) practices hematology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (NPI: 1396794574; TIN: 112419534) and primary practice location at 11702-4613. Desai is affiliated with the ilumed, LLC (ACO ID: D0005) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Desai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,110 traditional Medicare patients, billed 406,613 HCPCS/CPT codes, and received $4,942,704 in Medicare payments. The top billing code was 82728 (Ferritin (blood protein) level). Part D data shows 1,731 prescription claims across 211 beneficiaries totaling $8,354,428 in drug costs, led by Revlimid (Lenalidomide). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,717 to $4,942,704. Similarly, Part D prescription costs have moved sharply higher in recent years, from $22,416 to $8,354,428. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.5M$4.9M2016 Medicare payment: $3,717 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $250,160 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $733,341 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $500,333 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $976,281 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,609,983 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,445,360 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,147,595 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,942,704 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201622172$3,717
201723513,463$250,160
201831360,423$733,341
201934732,637$500,333
202077077,189$976,281
20211,098136,675$1,609,983
20221,172113,095$1,445,360
20232,564324,171$4,147,595
20243,110406,613$4,942,704

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.2M$8.4M2017 Drug cost: $22,416 (USD; Tot_Drug_Cst)2018 Drug cost: $54,847 (USD; Tot_Drug_Cst)2019 Drug cost: $225,879 (USD; Tot_Drug_Cst)2020 Drug cost: $535,050 (USD; Tot_Drug_Cst)2021 Drug cost: $3,302,461 (USD; Tot_Drug_Cst)2022 Drug cost: $4,655,262 (USD; Tot_Drug_Cst)2023 Drug cost: $7,334,984 (USD; Tot_Drug_Cst)2024 Drug cost: $8,354,428 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172281$22,416
201848136$54,847
201949146$225,879
202062226$535,050
2021172918$3,302,461
20221791,089$4,655,262
20231871,495$7,334,984
20242111,731$8,354,428

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
82728Ferritin (blood protein) level1,1301,958$13
80053Blood test, comprehensive group of blood chemicals1,6933,479$10
36415Insertion of needle into vein for collection of blood sample1,9114,746$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count1,9784,807$8
84100Phosphate level1,2042,090$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide651,694$1,049,211
Darzalex FasproDaratumumab-Hyaluronidase-Fihj491,379$609,933
AranespDarbepoetin Alfa In Polysorbat1994,404$466,805
OctagamImmun Globg(Igg)/Malt/Iga Ov50551,540$379,963
PomalystPomalidomide16448$367,296

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Amishi Desai?

Tedicare shows public-source Medicare data for Amishi Desai (NPI 1902141914), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amishi Desai have ACO affiliation data?

Amishi Desai is shown with ACO affiliation data for ilumed, LLC (REACH, ACO ID D0005) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Amishi Desai?

Amishi Desai is linked to NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (billing NPI 1396794574) in the available physician profile data.

Does Amishi Desai have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.